Sanofi et al v. Glenmark Generics Inc USA et al
Sanofi and Sanofi-Aventis U.S. LLC |
Glenmark Generics Inc USA and Glenmark Generics Ltd. |
1:2014cv00264 |
February 26, 2014 |
US District Court for the District of Delaware |
Wilmington Office |
XX Outside US |
Richard G. Andrews |
Patent |
35 U.S.C. ยง 271 |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 364 MEMORANDUM ORDER: Plaintiffs' Motion to Review Taxation of Costs (D.I. 359 ) is GRANTED (see Order for further details). Signed by Judge Richard G. Andrews on 12/7/2018. (nms) |
Filing 332 TRIAL OPINION. Sanofi is directed to submit an agreed-upon form of final judgment within two weeks. Signed by Judge Richard G. Andrews on 8/31/2016. (nms) |
Filing 204 MEMORANDUM OPINION providing claim construction for the multiple disputed terms in U.S. Patent Nos. 8,318,800, 7,323,493, and 8,410,167. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion. Signed by Judge Richard G. Andrews on 8/28/2015. (nms) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.